Abstract
Chronic venous insufficiency is a costly pathology affecting up to 30% of the US population. Prior studies have highlighted the substantial burden of resource utilization and work-loss costs associated with this disease, estimating upwards of 2 million workdays per year lost in the United States alone. Endovenous closure of refluxing superficial veins has proven to substantially improve health-related quality of life. Despite the shift from inpatient to outpatient ablation procedures, these minimally invasive techniques can still lead to loss of working days and economic disability.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
